Related to Fluidigm and 454 to Co-Promote Access Array and Sequencing Systems Worldwide

• $20M in Financing Helps RainDance Summon ThunderStorms for Myriad
  
• Real Time Genomics, JCVI Partner to Analyze iPSCs, Validate Reference Genome Variants
  
• Finishing Genomes with HGAP
  
• CollabRx, GeneInsight to Co-Market Informatics Solution
  
• Oncomed to Exploit Fluidigm’s Microfluidic Devices in Cancer Stem Cell Research
  
• Kyoto Buys Fluidigm’s Technology to Research Stem Cell Reprogramming
  
• Fluidigm and SABiosciences to Develop Pathway-Focused PCR Gene-Expression Panels
  
• SeqWright to Offer RainDance's Microdroplet-Based Sequence-Enrichment Platform
  
• Eurofins to Provide Roche GS Junior for Smaller-Scale Projects
  
• Illumina to Co-Market Caliper Technologies to Improve Sequencing Workflows
  
• Roche Acquires License to Nanopore Technology with Sights on $1,000 Whole Genome Sequencing
  
• 454, SoftGenetics Enter Co-Promotion Deal in Next-Gen Sequencing Informatics
  
• WaferGen Biosystems Picks Up RNA QC Technology from Rutgers
  
• WaferGen, Qiagen Sign Japan Marketing Agreement
  
• Roche and DNA Electronics to Develop Semiconductor-Based Sequencing System
  
• Roche and Precision System Science Deal to Advance NGS
  
• Fluidigm Selects IntegraGen as French Demonstrator Site for Its Technologies
  
• SAIC-Frederick and Fluidigm to Decode Genome of Epstein-Barr Virus
  
• RainDance Forges Separate Pacts with Ambry and Roche to Advance ADME Analysis
  
• IDT to Provide Custom Primers for Sequencing on 454’s GS FLX and GS Junior Platforms